Lin C C, Mo L R
Department of Surgery, Tainan Municipal Hospital, Taiwan.
Surg Laparosc Endosc. 1996 Aug;6(4):258-61.
Thoracoscopic (transthoracic endoscopic) sympathectomy, known worldwide as the best method for treatment of hyperhidrosis, is regarded as having two major contraindications: pleural adhesion and coagulopathy. We embarked on this study to prove that it is possible and highly feasible to do thoracoscopic sympathectomy, even in the presence of severe pleural adhesion, as long as the surgeon knows anatomy and is well-trained in performing this procedure. From October 1, 1989, through December 31, 1992, we treated 719 cases of hyperhidrosis palmaris (325 male and 394 female patients), by the thoracoscopic method at Tainan Municipal Hospital. Among them, 24 cases (3.5%), 19 male and 5 female patients, had concomitant pleural adhesions. The causes of pleural adhesion were pulmonary tuberculosis, chronic bronchitis, previous operations for hyperhidrosis, and a few with uncertain origins. Except for the first encountered case of hyperhidrosis with pleural adhesion, which was treated by mini-thoracotomy after failure of a thoracoscopic approach through the right thoracic cavity, the remainder of the 23 cases were treated successfully by the thoracoscopic method. In cases with bilateral pleural adhesions, the right thoracic cavity was more frequently involved and more severely. The incidence of pleural adhesion in hyperhidrosis is 3.5% in our series; all, except the first case, were treated thoracoscopically. Coagulopathy is for us, therefore, the only remaining contraindication of thoracoscopic sympathectomy.
胸腔镜(经胸内镜)交感神经切除术作为治疗多汗症的最佳方法,在全球范围内广为人知,被认为有两个主要禁忌症:胸膜粘连和凝血功能障碍。我们开展这项研究是为了证明,即使存在严重的胸膜粘连,只要外科医生熟悉解剖结构并接受过该手术的良好培训,进行胸腔镜交感神经切除术是可行且高度可行的。从1989年10月1日至1992年12月31日,我们在台南市立医院采用胸腔镜方法治疗了719例掌部多汗症患者(男性325例,女性394例)。其中,24例(3.5%)患者伴有胸膜粘连,男性19例,女性5例。胸膜粘连的原因包括肺结核、慢性支气管炎、既往多汗症手术以及少数病因不明的情况。除了首例伴有胸膜粘连的多汗症患者,在经右胸腔镜手术失败后采用小切口开胸手术治疗外,其余23例均通过胸腔镜方法成功治疗。在双侧胸膜粘连的病例中,右侧胸腔受累更为频繁且严重。在我们的系列研究中,多汗症患者胸膜粘连的发生率为3.5%;除第一例患者外,所有患者均通过胸腔镜进行了治疗。因此,对我们来说,凝血功能障碍是胸腔镜交感神经切除术唯一剩下的禁忌症。